Study
Probiotics May Ease Depression in Seniors with Cancer
Taking specific probiotics during chemotherapy for gastrointestinal cancer may reduce depression symptoms among older adults.
Summary
In plain language
Research has found that certain probiotics, known as psychobiotics, may help reduce depression in seniors undergoing chemotherapy for gastrointestinal cancer. The study involved patients who took either a probiotic or a placebo for four weeks. Those who received the probiotics showed improvements in their depression scores compared to those who did not. This finding suggests that including probiotics in treatment could support mental health during cancer care. Seniors might consider discussing the use of probiotics with their healthcare provider to see if it’s a suitable option for them.
Details
Use the full description to understand the study design, methods, and the limits of the findings.
A recent study explored the impact of probiotics on depression in seniors undergoing chemotherapy for gastrointestinal cancer.
The study was a randomized, double-blind trial involving patients who took either a psychobiotic or a placebo.
Results showed that those taking probiotics had better depression scores after treatment, suggesting a potential mental health benefit.
Limitations include a focus on a specific age group and cancer type, so results may not apply to everyone.
Consider discussing with your healthcare provider whether adding probiotics to your routine could be beneficial for your mental health during cancer treatment.
Full Study
Open the original publication for the complete methods, outcomes, and source material.
Probiotics May Ease Depression in Seniors with Cancer
Published October 2026
Opens at the publisher · external site · may require institutional access
Research Quality Score
Scored October 22, 2026 using rubric mq-1.8_2026-07-06.
Assessment
The study scored highly due to its rigorous randomized controlled trial design, comprehensive bias control measures, and robust statistical methods. Transparency was ensured through pre-registration and adherence to reporting standards. However, the lack of replication evidence and unspecified journal quality limited the overall score.
Category Breakdown
| Category | Score | Rating |
|---|---|---|
| Study design | 10.0/10 | |
| Bias control | 10.0/10 | |
| Statistical methods | 10.0/10 | |
| Reporting completeness | 10.0/10 | |
| Conflicts & funding | 10.0/10 | |
| Replication | 0.0/10 | |
| Relevance to chosen population | 10.0/10 | |
| Journal Reliability | 5.0/10 |
Additional Notes
This randomized, double-blind, placebo-controlled trial evaluated the effects of a psychobiotic formula on depression, anxiety, stress, and sleep disorders in patients undergoing chemotherapy after gastrointestinal cancer surgery. The study found significant improvements in these conditions with psychobiotic treatment compared to placebo.
Assessed on the study's full text across 8 quality dimensions; conflict-of-interest disclosures were reviewed.
Conditions This Research Covers
These condition pages help connect the paper back to the real-world health concerns it addresses.
Treatments Evaluated in This Research
Review the interventions studied here and compare them against the broader treatment library.
Take the next step
Build a personalized plan using research-backed studies, conditions, and treatments.